Cansativa Group
Timm Hocke has a wealth of work experience, beginning in 2012 when they were CFO and CEO at TD Books. In 2013, they took a summer internship at Deutsche Bahn, followed by a gap year as a consultant at McKinsey & Company and Volkswagen Inhouse Consulting in 2014. Timm then moved to PwC Consulting in 2014, followed by a role as a Business Strategy Consultant at Roland Berger in 2015. In 2016, they were a Senior Business Consultant at Campana & Schott, followed by a Senior Consultant & Operations Manager at Dierks+Company in 2017. From 2019 to 2022, they were Head of Corporate Projects & Strategy and Manager Corporate Projects at BIOTRONIK, and is currently Chief Commercial Officer (CCO) and Chief Of Staff at Cansativa GmbH.
Timm Hocke obtained a Bachelor of Business Administration - BBA in Economics from Lander University between 2010 and 2013. Timm then went on to pursue a Master's Degree in Economics from Freie Universität Berlin from 2014 to 2016.
Cansativa Group
Cansativa provides independent market access and extensive warehousing and distribution capacities. Founded in 2017 and headquartered in Moerfelden-Walldorf, Germany, Cansativa is a GMP and GDP certified pharmaceutical company licensed for manufacturing, import and trade in pharmaceuticals as well as trade in controlled substances. Cansativa is committed to the goal of professionalizing the medical cannabis market, eliminating stigmatization surrounding it, and reducing prices for patients. Since the very beginning, Cansativa has operated its own distribution and fulfillment center, and as one of the “first movers” in the